ALASTIN Skincare has appointed James P. Hartman to the position of chief commercial officer. Hartman most recently served as vice president and general manager at Solta Medical, a division of Valeant Pharmaceuticals. Prior to Solta, he was VP and U.S. head of aesthetics & OTC at Merz Aesthetics and VP of global marketing and business development at Obagi Medical.
“We are extremely pleased to have Jim join ALASTIN as a key member of the executive team to lead our commercialization activities as we continue the rapid growth of our current products and build our product pipeline,” said Diane S. Goostree, president and CEO of ALASTIN Skincare. “Jim’s extensive operating background in the medical aesthetics space, including experience with energy-based rejuvenating devices, is a natural fit for us as we develop and launch new products and expand our sales force.”
Image: James P. Hartman
